Taming the Beast

Krysti Hughett shares her experience as a breast cancer survivor and advocate.  

KATHY LATOUR
PUBLISHED: 1:00 AM, SUN DECEMBER 6, 2009
Talk about this article with other patients, caregivers, and advocates in the Breast CURE discussion group.
Krysti Hughett listens intently to the woman on the other end of the phone. From her side of the conversation, it’s clear—there is one more breast cancer survivor now living in Hughett’s home city of Indianapolis, Indiana. She reassures the woman and then offers to have someone from the Young Survival Coalition office, where Hughett is a resource specialist, to go with the woman to the doctor.

It’s a 24/7 job for Hughett, and one she embraces with the enthusiasm of a zealot despite dealing with her own ongoing treatment for lung metastases. Diagnosed with stage 4 bilateral inflammatory breast cancer in March 2005, Hughett, 45, was told, until the day she was diagnosed, that the rash on both her breasts was not breast cancer. It made sense to Hughett, who was convinced that the rash was a reaction to a new feather mattress her husband bought a month before. 

“There was no lump, and a mammogram and sonogram three days before diagnosis showed nothing,” she says. “I was a medical consumer who had followed my breast [exams] since age 20 when I had a benign lump—but I was willing to believe the medical professionals.” 

It was a young family internist who prompted Hughett to push for a diagnosis, setting her up with a surgeon while eight core biopsies were being analyzed. Hughett says the surgeon didn’t think it was breast cancer, but conceded that he had no idea what he was looking at and suggested she go to his mentor and teacher Robert Goulet, MD, at the Indiana University Melvin and Bren Simon Cancer Center. 

“Dr. Goulet knew by looking at it that it was inflammatory breast cancer,” Hughett says. 

From there things moved quickly. After four weeks of chemotherapy, Hughett had a bilateral mastectomy. The cancer continued to confound doctors by coming back as triple negative, and then showing as HER2-positive in later pathology. Scans also showed multiple spots on her lungs, meaning the cancer was stage 4. 

It was a shock for Hughett, the mother of three daughters—the youngest only 6. 

She immediately began preoperative chemotherapy, and had a rush, she says, when she realized she was sitting in the same chemo chair that Lance Armstrong used when he got his chemo from Lawrence Einhorn, MD, at Indiana University. Then she began researching her condition. 

“Two weeks after surgery, I met Ginny Mason, the executive director of the Inflammatory Breast Cancer Research Foundation, who was doing a meeting in Indianapolis,” Hughett says. “I walked in and met all these inflammatory women, and it was amazing.” 

Hughett says she dived right into the information, saying her motto has always been, “better the beast I know than the one I don’t.” 

Since then Hughett has advocated for herself by seeking out three clinical trials that have kept her lung mets stable. She jokes that she comes to SABCS to shop for her next clinical trial. 

“I am a clinical trial junky,” she says. 

Talk about this article with other patients, caregivers, and advocates in the Breast CURE discussion group.
Special Feature
Share Your Art
Related Articles
Failure to Communicate: I Have Cancer But I'm OK
Am I alone in wanting to reassure everyone I meet?
New Therapy Shows Early Promise, Continues to Progress in Triple-Negative Breast Cancer
The designation, which will expedite the development and review of sacituzumab govitecan in TNBC, is based on a phase 2 trial in which the therapy induced a response rate of 31 percent in heavily pretreated patients with metastatic TNBC.
Flat and Fabulous: Life After Breast Cancer and a Double Mastectomy
Learning to accept my body after a double mastectomy.
Related Videos
Amanda L. Kong on Seeking a Second Opinion for Breast Cancer Care at a High Volume Hospital
Amanda L. Kong, discusses why patients should consider seeking a second opinion for their breast cancer diagnosis and care at a high volume hospital.
Amanda L. Kong on Breast Cancer Care at High Volume Hospitals
This study sought to identify patterns of breast cancer care at high volume hospitals.
Anees B. Chagpar on What to Expect After Contralateral Prophylactic Mastectomy
Anees B. Chagpar, director of the Breast Center at Smilow Cancer Hospital at Yale-New Haven, discusses what a patient can expect following a contralateral prophylactic mastectomy.
$auto_registration$